Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission

IFITM3, TLR3, and CD55 Gene SNPs and Cumulative Genetic Risks for Severe Outcomes in Chinese Patients With H7N9/H1N1pdm09 Influenza

(2017) Nelson Lee et al.   JOURNAL OF INFECTIOUS DISEASES

Natural mutations in IFITM3 modulate post‐translational regulation and toggle antiviral specificity

(2016) Alex A Compton et al.   EMBO REPORTS

IFITM3 and severe influenza virus infection. No evidence of genetic association

(2016) M. López-Rodríguez et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Hospitalization Risk Due to Respiratory Illness Associated with Genetic Variation at IFITM3 in Patients with Influenza A(H1N1)pdm09 Infection: A Case-Control Study

(2016) Vânia Gaio et al.   PLoS One

A global reference for human genetic variation

(2015) Richard A. Gibbs et al.   NATURE

Genome-Wide Association Study of Serum Creatinine Levels during Vancomycin Therapy

(2015) Sara L. Van Driest et al.   PLoS One

Identification of an endocytic signal essential for the antiviral action of IFITM3

(2014) Rui Jia et al.   CELLULAR MICROBIOLOGY

Phosphorylation of the Antiviral Protein Interferon-inducible Transmembrane Protein 3 (IFITM3) Dually Regulates Its Endocytosis and Ubiquitination

(2014) Nicholas M. Chesarino et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

IFITM3 Restricts Influenza A Virus Entry by Blocking the Formation of Fusion Pores following Virus-Endosome Hemifusion

(2014) Tanay M. Desai et al.   PLoS Pathogens

Influenza Vaccination Is Not Associated With Detection of Noninfluenza Respiratory Viruses in Seasonal Studies of Influenza Vaccine Effectiveness

(2013) M. E. Sundaram et al.   CLINICAL INFECTIOUS DISEASES

Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates

(2013) Suzanne E. Ohmit et al.   CLINICAL INFECTIOUS DISEASES

IFITM3 and Susceptibility to Respiratory Viral Infections in the Community

(2013) T. C. Mills et al.   JOURNAL OF INFECTIOUS DISEASES

The CD225 Domain of IFITM3 Is Required for both IFITM Protein Association and Inhibition of Influenza A Virus and Dengue Virus Replication

(2013) S. P. John et al.   JOURNAL OF VIROLOGY

Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005–2011

(2013) Deliana Kostova et al.   PLoS One

Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection

(2013) Z. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals

(2013) Yong-Hong Zhang et al.   Nature Communications

Effectiveness of Seasonal Influenza Vaccines in the United States During a Season With Circulation of All Three Vaccine Strains

(2012) J. J. Treanor et al.   CLINICAL INFECTIOUS DISEASES

The N-Terminal Region of IFITM3 Modulates Its Antiviral Activity by Regulating IFITM3 Cellular Localization

(2012) R. Jia et al.   JOURNAL OF VIROLOGY

IFITM3 restricts the morbidity and mortality associated with influenza

(2012) Aaron R. Everitt et al.   NATURE

Ifitm3 Limits the Severity of Acute Influenza in Mice

(2012) Charles C. Bailey et al.   PLoS Pathogens

The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies

(2011) Catherine A McCarty et al.   BMC Medical Genomics

Knowledge-Driven Multi-Locus Analysis Reveals Gene-Gene Interactions Influencing HDL Cholesterol Level in Two Independent EMR-Linked Biobanks

(2011) Stephen D. Turner et al.   PLoS One

Influenza vaccine effectiveness in Wisconsin during the 2007–08 season: Comparison of interim and final results

(2011) Edward A. Belongia et al.   VACCINE

H5N1 Influenza Virus Pathogenesis in Genetically Diverse Mice Is Mediated at the Level of Viral Load

(2011) A. C. M. Boon et al.   mBio

IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry

(2011) Eric M. Feeley et al.   PLoS Pathogens

Complications of seasonal and pandemic influenza

(2010) Michael B. Rothberg et al.   CRITICAL CARE MEDICINE

The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus

(2009) Abraham L. Brass et al.   CELL

Host Genetic Variation Affects Resistance to Infection with a Highly Pathogenic H5N1 Influenza A Virus in Mice

(2009) A. C. M. Boon et al.   JOURNAL OF VIROLOGY

Host Genetic Background Strongly Influences the Response to Influenza A Virus Infections

(2009) Barkha Srivastava et al.   PLoS One

Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort

(2009) Stephanie A. Irving et al.   VACCINE

Complications of Viral Influenza

(2008) Michael B. Rothberg et al.   AMERICAN JOURNAL OF MEDICINE

Development of a Large-Scale De-Identified DNA Biobank to Enable Personalized Medicine

(2008) DM Roden et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004–2005 Season to the 2006–2007 Season

(2008) Edward A. Belongia et al.   JOURNAL OF INFECTIOUS DISEASES

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

(2008) Jens Wrammert et al.   NATURE